Hyundai Motor Company is evaluating plans to significantly increase production at its Georgia assembly plant, located near Savannah. The company’s CEO, Jose Munoz, disclosed that the Georgia Metaplant’s annual production capacity could rise from the originally planned 500,000 vehicles to somewhere between 700,000 and 800,000 by 2028. This potential expansion fits within Hyundai’s broader strategy to invest approximately $26 billion in the United States through 2028.
The Georgia assembly facility, also known as Hyundai Motor Group Metaplant America (HMGMA), represents a substantial commitment to domestic manufacturing of electric vehicles (EVs), hybrids, and gas-powered models for Hyundai, Kia, and Genesis brands. The plant initially aimed to produce 300,000 vehicles annually upon opening, a capacity that has already been increased to 500,000 in recent years and may be pushed even further with this prospective development.
If the capacity increase proceeds, Hyundai’s Georgia plant would become one of the largest automotive assembly sites in the U.S. in terms of volume. This expansion would also support the company’s ambitions to capture a larger share of the North American market through a strong focus on clean energy vehicles and electrification technologies.
Alongside assembly expansions, Hyundai is reportedly exploring additional U.S. investments in related vehicle segments, including trucks and SUVs. While details on those initiatives remain limited, the moves complement Georgia’s growing stature as a hub for automotive manufacturing and supply chain development.
The effort also aligns with industry trends emphasizing domestic production, especially amidst evolving trade policies and incentives encouraging localized manufacturing for critical vehicle components and finished products.
Though not yet finalized, Hyundai’s consideration of elevating production capacity at the Georgia plant highlights ongoing growth and investment momentum in U.S.-based automotive manufacturing. The potential increase is subject to operational planning, market demand, and regulatory approvals as the company charts its future production roadmap.
